Ascott Residence Trust – DPU accretive deal to enlarge asset base by one-third July 5, 2019 1463

PSR Recommendation: ACCUMULATE Status: Downgraded
Target Price: S$1.36

What’s in the news?

  • ART will acquire all the issued and paid-up stapled units in AHT (not rated) for a consideration of S$1.0868 per share. Purchase consideration will be S$0.0543 per share in cash and 0.7942 units of ART.
  • Consideration is based on a gross exchange ratio of 0.836x price to NAV and represents a 7% premium to AHT’s NAVPS and a 32% premium to 12-month VWAP.
  • Combined entity will have an AUM of S$7.6bn (+33%) and more than 206,000 keys under management across 15 countries.
  • The proposed merger is subject to shareholder votes at respective EGMs to be convened in October 2019. Both trusts require a 50%+1 vote majority (an additional requirement of ≥75% votes for AHT), from which ART and AHT affiliated unitholders will abstain from voting.

 

The Positives

  • Proposed ART-AHT merger to be 2.5% DPU accretive and NAV neutral. The combination will see the injection of 14 income producing assets into the trust which lends a 2.5% DPU accretion for ART unitholders (DPU +1.8% for AHT).

 

  • Enlarged portfolio into APAC with debt headroom of c.S$1bn. The diversification, growth and stability story remains intact. 66% of the middle-class population will be represented by Asia and ART’s increased presence in APAC (71%) will allow ART to capture the growth in disposal income and travel associated with this demographic. The portion of profit sourced from stable lease types (master lease and management contracts with minimum guaranteed income (MCMGI)) will increase by 400bps to 46%.

 

  • Combined entity will be the largest hospitality trust in APAC and eighth largest trust globally, facilitating index inclusion. The enlarged trust will have better pricing power on their cost of borrowing and the increased market capitalisation helps the trust to meet the investable market cap criteria for inclusion into the FTSE Nareit Developed Index. 100% of earning from AHT assets are derived from development markets, putting ART’s earning from developed market post-combination at 82%, well above the 75% minimum for index inclusion. This is a positive externality of the increased size, which adds to the merit of the deal. The free float of the combined entity is expected to increase by c.50%.

 

The Negatives

  • Increased exposure to soft markets, Australia (+9ppts) and Japan (+5ppts). These two geographies face substantial room supply coming onto the market in the next three years which will add downward pressure to ADRs. The addition of AHT’s assets to the portfolio will increase ART’s presence from 14 countries to 15 countries but the concentration risk in the top four geographies has increased marginally from 47% to 51%, with greatest exposure to soft markets Australia (18%) and Japan (18%).

    All six of the assets in Australia are under management contracts and dependent on the profitability of the hotels. All five hotels in Japan are operating under a master lease and have a minimum base rent with a variable component. Despite the supply coming online, Japan hotels will still stand to reap the potential upside from the 2019 Rugby World Cup and the 2020 Olympics, while remaining protected by fixed rents post 2020.

 

Outlook

Immediate DPU accretion is a strong case for the combination of ART-AHT. The combination will result in a more geographically diversified entity, positioned to capture growth in APAC markets. Inclusion in the FTSE Nareit Index will be the cherry on the top.

 

Downgrade to ACCUMULATE, unchanged target price of $1.36.

We downgrade our call to ACCUMULATE due to the recent appreciation in the share price. This translates to a dividend yield of 5.5% and a FY19e P/NAV of 0.88. No change in our target price as the transaction is still pending shareholder approval.

Important Information

This report is prepared and/or distributed by Phillip Securities Research Pte Ltd ("Phillip Securities Research"), which is a holder of a financial adviser’s licence under the Financial Advisers Act, Chapter 110 in Singapore.

By receiving or reading this report, you agree to be bound by the terms and limitations set out below. Any failure to comply with these terms and limitations may constitute a violation of law. This report has been provided to you for personal use only and shall not be reproduced, distributed or published by you in whole or in part, for any purpose. If you have received this report by mistake, please delete or destroy it, and notify the sender immediately.

The information and any analysis, forecasts, projections, expectations and opinions (collectively, the “Research”) contained in this report has been obtained from public sources which Phillip Securities Research believes to be reliable. However, Phillip Securities Research does not make any representation or warranty, express or implied that such information or Research is accurate, complete or appropriate or should be relied upon as such. Any such information or Research contained in this report is subject to change, and Phillip Securities Research shall not have any responsibility to maintain or update the information or Research made available or to supply any corrections, updates or releases in connection therewith.

Any opinions, forecasts, assumptions, estimates, valuations and prices contained in this report are as of the date indicated and are subject to change at any time without prior notice. Past performance of any product referred to in this report is not indicative of future results.

This report does not constitute, and should not be used as a substitute for, tax, legal or investment advice. This report should not be relied upon exclusively or as authoritative, without further being subject to the recipient’s own independent verification and exercise of judgment. The fact that this report has been made available constitutes neither a recommendation to enter into a particular transaction, nor a representation that any product described in this report is suitable or appropriate for the recipient. Recipients should be aware that many of the products, which may be described in this report involve significant risks and may not be suitable for all investors, and that any decision to enter into transactions involving such products should not be made, unless all such risks are understood and an independent determination has been made that such transactions would be appropriate. Any discussion of the risks contained herein with respect to any product should not be considered to be a disclosure of all risks or a complete discussion of such risks.

Nothing in this report shall be construed to be an offer or solicitation for the purchase or sale of any product. Any decision to purchase any product mentioned in this report should take into account existing public information, including any registered prospectus in respect of such product.

Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may provide an array of financial services to a large number of corporations in Singapore and worldwide, including but not limited to commercial / investment banking activities (including sponsorship, financial advisory or underwriting activities), brokerage or securities trading activities. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have participated in or invested in transactions with the issuer(s) of the securities mentioned in this report, and may have performed services for or solicited business from such issuers. Additionally, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have provided advice or investment services to such companies and investments or related investments, as may be mentioned in this report.

Phillip Securities Research or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report may, from time to time maintain a long or short position in securities referred to herein, or in related futures or options, purchase or sell, make a market in, or engage in any other transaction involving such securities, and earn brokerage or other compensation in respect of the foregoing. Investments will be denominated in various currencies including US dollars and Euro and thus will be subject to any fluctuation in exchange rates between US dollars and Euro or foreign currencies and the currency of your own jurisdiction. Such fluctuations may have an adverse effect on the value, price or income return of the investment.

To the extent permitted by law, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may at any time engage in any of the above activities as set out above or otherwise hold an interest, whether material or not, in respect of companies and investments or related investments, which may be mentioned in this report. Accordingly, information may be available to Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, which is not reflected in this report, and Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may, to the extent permitted by law, have acted upon or used the information prior to or immediately following its publication. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited its officers, directors, employees or persons involved in the issuance of this report, may have issued other material that is inconsistent with, or reach different conclusions from, the contents of this report.

The information, tools and material presented herein are not directed, intended for distribution to or use by, any person or entity in any jurisdiction or country where such distribution, publication, availability or use would be contrary to the applicable law or regulation or which would subject Phillip Securities Research to any registration or licensing or other requirement, or penalty for contravention of such requirements within such jurisdiction.

This report is intended for general circulation only and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. The products mentioned in this report may not be suitable for all investors and a person receiving or reading this report should seek advice from a professional and financial adviser regarding the legal, business, financial, tax and other aspects including the suitability of such products, taking into account the specific investment objectives, financial situation or particular needs of that person, before making a commitment to invest in any of such products.

This report is not intended for distribution, publication to or use by any person in any jurisdiction outside of Singapore or any other jurisdiction as Phillip Securities Research may determine in its absolute discretion.

IMPORTANT DISCLOSURES FOR INCLUDED RESEARCH ANALYSES OR REPORTS OF FOREIGN RESEARCH HOUSE

Where the report contains research analyses or reports from a foreign research house, please note:

  1. recipients of the analyses or reports are to contact Phillip Securities Research (and not the relevant foreign research house) in Singapore at 250 North Bridge Road, #06-00 Raffles City Tower, Singapore 179101, telephone number +65 6533 6001, in respect of any matters arising from, or in connection with, the analyses or reports; and
  2. to the extent that the analyses or reports are delivered to and intended to be received by any person in Singapore who is not an accredited investor, expert investor or institutional investor, Phillip Securities Research accepts legal responsibility for the contents of the analyses or reports.
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments

Get access to all the latest market news, reports, technical analysis
by signing up for a free account today!